机构:[1]Division of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[2]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China四川大学华西医院
We are grateful to the National Key Programs of China
during the 12th Five-Year Plan Period (Grant 2012ZX0910
3101-033), National Natural Science Foundation of China
(81402782) and China Postdoctoral Science Foundation
(2014M552373).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类|3 区医学
小类|3 区药物化学4 区生化与分子生物学
最新[2023]版:
大类|4 区医学
小类|4 区生化与分子生物学4 区药物化学
第一作者:
第一作者机构:[1]Division of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China[2]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China
通讯作者:
推荐引用方式(GB/T 7714):
Jinying Chen,Liang Ma,Li Huang,et al.Discovery of a Potent 9-Deazaxanthine-based Agent for the Treatment of Obesity-Related Non-alcoholic Fatty Liver Disease.[J].Chemical biology & drug design.2015,86(1):66-79.doi:10.1111/cbdd.12429.
APA:
Jinying Chen,Liang Ma,Li Huang,Caifeng Xie,Heying Pei...&Lijuan Chen.(2015).Discovery of a Potent 9-Deazaxanthine-based Agent for the Treatment of Obesity-Related Non-alcoholic Fatty Liver Disease..Chemical biology & drug design,86,(1)
MLA:
Jinying Chen,et al."Discovery of a Potent 9-Deazaxanthine-based Agent for the Treatment of Obesity-Related Non-alcoholic Fatty Liver Disease.".Chemical biology & drug design 86..1(2015):66-79